Roivant Sciences (NASDAQ: ROIV) director exercises 70K options, sells 70K shares

Rhea-AI Filing Summary

Roivant Sciences director Meghan Fitzgerald exercised stock options for 70,000 Common Shares at an exercise price of $8.80 per share and immediately sold the same 70,000 shares in an open-market transaction. The sale had a weighted average price of $27.45 per share, with individual trades executed between $27.32 and $27.80. Following these transactions, Fitzgerald directly holds 42,963 Common Shares, and the exercised option award is now fully vested and exhausted.

Insights

Equity compensation analyst

Director exercised options and sold the resulting shares in a routine liquidity move.

Director Meghan Fitzgerald exercised stock options for 70,000 Common Shares at an exercise price of $8.80 and sold the same number of shares at a weighted average of $27.45. This is a classic exercise-and-sell pattern, turning an equity award into cash.

The filing shows no remaining derivative holdings related to this option grant, indicating a full exercise. After the sale, Fitzgerald continues to hold 42,963 Common Shares directly. With only this filing’s data, the event appears to be a routine disposition of an equity award rather than a thesis-changing signal.

Insider Trade Summary

Net Seller: 70,000 shares ($1,921,500)

Net Sell 3 txns

Insider Fitzgerald Meghan

Role Director

Sold 70,000 shs ($1.92M)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	70,000	$0.00	--
Exercise	Common Shares	70,000	$8.80	$616K
Sale	Common Shares	70,000	$27.45	$1.92M

Holdings After Transaction: Stock Option (Right to Buy) — 48,578 shares (Direct); Common Shares — 112,963 shares (Direct)

Footnotes (1)

1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.32 to $27.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. Award of stock options to purchase Common Shares that is fully vested.

Key Figures

Options exercised: 70,000 shares Exercise price: $8.80/share Shares sold: 70,000 shares +3 more

6 metrics

Options exercised 70,000 shares Stock options exercised at $8.80 per share on Common Shares

Exercise price $8.80/share Exercise or conversion price for 70,000 stock options

Shares sold 70,000 shares Common Shares sold in open-market transaction on same date

Weighted average sale price $27.45/share Average price for multiple sales between $27.32 and $27.80

Post-transaction holdings 42,963 shares Common Shares directly held after the sale

Option expiration April 19, 2033 Original expiration date of exercised stock option award

Key Terms

Stock Option (Right to Buy), weighted average price, open-market sale, fully vested

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

weighted average price financial

"The price reported in column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

fully vested financial

"Award of stock options to purchase Common Shares that is fully vested."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fitzgerald Meghan

(Last) (First) (Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON SW1H 0DB

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/26/2026		M		70,000	A	$8.8	112,963	D
Common Shares	03/26/2026		S		70,000	D	$27.45(1)	42,963	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$8.8	03/26/2026		M			70,000	(2)	04/19/2033	Common Stock	70,000	$0	48,578	D

Explanation of Responses:

1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.32 to $27.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

2. Award of stock options to purchase Common Shares that is fully vested.

	By: /s/ Jo Chen, as Attorney-in-Fact for Meghan FitzGerald	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Roivant Sciences (ROIV) director Meghan Fitzgerald do in this Form 4?

Meghan Fitzgerald exercised stock options for 70,000 Roivant Sciences Common Shares at $8.80 per share, then sold the same 70,000 shares in an open-market transaction at a weighted average price of $27.45, realizing value from a fully vested award.

At what prices were the Roivant Sciences (ROIV) shares sold by the director?

The reported sale used a weighted average price of $27.45 per share. According to the filing, individual trades occurred in multiple transactions at prices ranging from $27.32 to $27.80 per share, inclusive, all on the same transaction date.

How many Roivant Sciences (ROIV) shares does the director hold after these transactions?

After exercising options and selling 70,000 Common Shares, director Meghan Fitzgerald directly holds 42,963 Roivant Sciences Common Shares. The derivativeSummary in the filing is empty, indicating no remaining option position from this particular award after the reported exercise.

What does the option exercise in the Roivant Sciences (ROIV) Form 4 represent?

The Form 4 shows an exercise of fully vested stock options to buy 70,000 Common Shares at an exercise price of $8.80 per share. This converts a derivative award into common stock, which was then sold the same day in open-market transactions.

Were the Roivant Sciences (ROIV) transactions in this Form 4 open-market trades?

Yes. The filing identifies the 70,000 Common Shares disposition with transaction code S, described as a sale in the open market or private transaction. The shares were sold at prices between $27.32 and $27.80 per share, with a weighted average of $27.45.